Document ID: chunk:federal_register_of_legislation:F2022L01380:reg:7
Version: federal_register_of_legislation:F2022L01380
Segment Type: reg
Provision Reference: reg 7
Character Range: 1738–3839

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about malignant neoplasm of unknown primary site and death from malignant neoplasm of unknown primary site.
Meaning of malignant neoplasm of unknown primary site
(2)          For the purposes of this Statement of Principles, malignant neoplasm of unknown primary site:
(a)          means a histologically confirmed metastatic malignant neoplasm for which the primary tumour site cannot be identified after a complete history, physical examination and appropriate diagnostic investigations have been carried out; and
(b)          excludes:
(i)            haematolymphoid tumours (including non-Hodgkin lymphoma and Hodgkin's lymphoma);
(ii)         malignant melanoma; and
(iii)       mesenchymal tumours (including soft tissue sarcoma).
Note: Histological types of malignant neoplasm of unknown primary site include adenocarcinomas, squamous cell carcinomas, neuroendocrine tumours and poorly differentiated or undifferentiated neoplasms.
(3)          While malignant neoplasm of unknown primary site attracts ICD‑10‑AM code C80, in applying this Statement of Principles the meaning of malignant neoplasm of unknown primary site is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from malignant neoplasm of unknown primary site
(5)          For the purposes of this Statement of Principles, malignant neoplasm of unknown primary site, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of unknown primary site.
Note: terminal event is defined in the Schedule 1 – Dictionary.